The In-Vitro Fertilization Market, valued at USD 25.57 Billion in 2023, is anticipated to surpass USD 44.28 Billion by 2032, reflecting a projected CAGR of 6.4%

Growth is likely to be driven by increasing infertility and advanced technology such as lensless sperm imaging. According to the American Society for Reproductive Medicine (ASRM), infertility affects around 6.7 million US women, which account for approximately 11.0 percent of the reproductive population. In addition, 25% of pairs have more than one infertility factor. The average age of the married and first child of women and men is growing. The number of women seeking IVF therapy has grown. In addition, several women freeze up their eggs to have a child in the future to focus on their careers. The government's funding for egg-sperm freezing is expected to reduce the chances of multiple pregnancies, technological developments enabling genetic disorder preidentification, and several industrial revolutions to boost market growth.

In-Vitro Fertilization Market Statistics

• The global in-vitro fertilization market was valued at USD 25.57 billion in 2023
• The market is projected to increase at a stable annual pace of 6.4% from 2024-2032
• Europe accounts for 37% of the in-vitro fertilization market
• Asia-Pacific is growing at a CAGR of 7.2% within the in-vitro fertilization market
• The fertility clinics end-use has the largest earning in-vitro fertilization market
• The market has seen significant revenue growth from culture media instrument
• Rising demand for fertility preservation among cancer patients drives market expansion is a trend in the in-vitro fertilization market

Download Sample Report Copy:https://www.acumenresearchandconsulting.com/request-sample/1278

In-Vitro Fertilization Market Dynamics

Instrument Segment is Emerging in the In-Vitro Fertilization Market

IVF includes of culture media, capital equipment, and disposable IVF devices. Because of increased government financing, expanded research activities to develop culture media, and the capacity to keep sperm despite diminishing its quality, cultural media had the largest market share in 2023. The primary media used in in-vitro fertilization are semen processing media, cryopreservation media, egg processing media, and embryonic culture media. The demand for egg processing medium is also expected to rise in the coming years, as large egg cryobanks are established.

The industry's players introduce not reusable devices such as slides, needles, chambers and others with the necessitate for elevated standard of sterile conditions and strict regulatory requirements. Therefore, during the projection period, the segment of disposable equipment will increase at the fastest rate. Increasingly, demand or capital resources are expected to grow as patients opt for in-vitro fertilization and game freezing. As a result, businesses develop high-automation equipment.

Rising Popularity of Minimal Stimulation IVF is the In-Vitro Fertilization Market Trend

A prominent trend influencing the in-vitro fertilization (IVF) market is the growing preference for low stimulation IVF, also known as mini-IVF. This method uses lower doses of fertility medications to stimulate the ovaries, lowering medication-related adverse effects and treatment expenses. Patients seeking a more natural, less invasive alternative are increasingly choosing this procedure. Mini-IVF also reduces the risk of ovarian hyperstimulation syndrome (OHSS), making it a safer option for women with polycystic ovary syndrome (PCOS) or other hormonal problems. Furthermore, advances in embryo freezing and laboratory techniques have increased the success rates of low stimulation IVF, propelling its widespread acceptance. As awareness grows, this tendency is projected to have a substantial impact on market growth.

In-Vitro Fertilization Market Growth Driven by Increasing Fresh Nondonor Procedure Types

The market was divided into fresh, frozen, nondonorous, fresh donors and frozen donors based on the type. Due to the high success rate in the first attempt, the new non-donor segment accounted for the largest market share in 2023. The frozen nondonor segment will probably experience the most rapid growth in the next few years because it can be used in complicated cases, such as Ovarian Hyperstimulation Syndrome (OHSS) patients. Moreover, better implantation rate, increased birth rate for live children, more birth weight, lower rate of erroneous pregnancy and reduced ectopic pregnancies, during the forecast period, are expected to drive demand for the procedure.

In-Vitro Fertilization Market Segmentation

The global in-vitro fertilization market is classified into 5 segments: instrument, type, procedure type, end-use, and regional markets

• Instrument: culture media, disposable devices, and equipment
• Type: conventional IVF, IVF with donar eggs, and IVF with ICSI
• Procedure type: frozen non-donor, fresh non-donor, frozen donor, and fresh donor
• End-Use: fertility clinics, hospitals, and others
• Regional: the Middle East & Africa, Asia-Pacific, Europe, Latin America, and North America

In-Vitro Fertilization Market Regional Outlook

Europe dominated the market in 2023 by removing the term "experimental" from egg cryopreservation and becoming the first to award legal clearance to IVF or mitochondrial transfer technology, as it was the first region to implement this process. Furthermore, the expansion is fueling medical tourism in Europe. People fly from the United States to the Czech Republic due to the expense. Institutes introduce innovative technology that provides an economical way to boost success rates. For example, the Valencian Infertility Institute in Spain has developed many fertility procedures to improve treatment success rates. France, Germany, and United Kingdom They are the region's leading contributors. Every year, over 19,000 ART births are registered in France. Furthermore, in July 2015, French legislation permitted the legalization of substitute children, granting them the same rights and nationality as ordinary French children.

In-Vitro Fertilization Market Players

In-vitro fertilization companies profiled in the report include Kitazato Corporation, Cook Medical, Hamilton Thorne, Inc., Esco Micro Pte Ltd, Rocket Medical plc, Genea Limited, Merck KGaA, Thermo Fisher Scientific, Inc., Ferring Pharmaceuticals, Vitrolife AB, Nidacon International AB, and EMD Serono.

Buy Now This Report:https://www.acumenresearchandconsulting.com/buy-now/0/1278

In-Vitro Fertilization Market Insights

Mr. Richard Johnson

Acumen Research and Consulting

India: +91 8983225533

E-mail: [email protected]